The Effect of Modified Sham Feeding With Orlistat in Overweight and Obese Subjects: A Pilot Study
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 08 Jun 2014
At a glance
- Drugs Orlistat (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 24 May 2013 Planned end date changed from 1 Aug 2013 to 1 Nov 2013 as reported by ClinicalTrials.gov.
- 24 May 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 06 Dec 2012 New trial record